# Ironwood Pharmaceuticals (IRWD) — Earnings

IRWD · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/irwd/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $0.31 |
| EPS estimate | $0.32 |
| EPS surprise | −3.13% |
| Revenue surprise | −1.14% |
| Revenue | $113.0M |
| Revenue estimate | $114.3M |
| Reported | Aug 6, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1446847/000110465926091987/irwd-20260630x10q.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 6, 2026 | $0.32 | $0.31 | -3.13% | $114.3M | $113.0M |
| Q1 2026 | May 7, 2026 | $0.25 | $0.24 | -2.72% | $92.1M | $106.5M |
| Q4 2025 | Feb 25, 2026 | −$0.07 | −$0.01 | 84.62% | $50.9M | $47.7M |
| Q3 2025 | Nov 10, 2025 | $0.11 | $0.23 | 117.60% | $74.7M | $122.1M |
| Q2 2025 | Aug 7, 2025 | $0.02 | $0.14 | 500.86% | $60.8M | $85.2M |
| Q1 2025 | May 7, 2025 | −$0.14 | −$0.23 | -68.87% | $45.9M | $41.1M |
| Q4 2024 | Feb 27, 2025 | $0.08 | $0.02 | -76.36% | $93.8M | $90.5M |
| Q3 2024 | Nov 7, 2024 | $0.07 | $0.02 | -72.22% | $91.2M | $91.6M |
| Q2 2024 | Aug 8, 2024 | $0.16 | −$0.01 | -106.41% | $107.1M | $94.4M |
| Q1 2024 | May 9, 2024 | $0.20 | −$0.03 | -114.85% | $105.8M | $74.9M |
| Q4 2023 | Feb 15, 2024 | $0.20 | −$0.01 | -105.00% | $117.5M | $117.6M |
| Q3 2023 | Nov 9, 2023 | $0.20 | $0.09 | -55.88% | $114.0M | $113.7M |
| Q2 2023 | Aug 8, 2023 | $0.25 | −$6.84 | -2872.60% | $103.7M | $107.4M |
| Q1 2023 | May 4, 2023 | $0.25 | $0.25 | 1.34% | $100.3M | $104.1M |
| Q4 2022 | Feb 16, 2023 | $0.28 | $0.27 | -2.88% | $108.0M | $107.2M |
| Q3 2022 | Nov 3, 2022 | $0.27 | $0.28 | 3.70% | $109.2M | $108.6M |
| Q2 2022 | Aug 4, 2022 | $0.33 | $0.21 | -35.96% | $103.6M | $97.2M |
| Q1 2022 | May 5, 2022 | $0.32 | $0.21 | -33.33% | $96.6M | $97.5M |
| Q4 2021 | Feb 17, 2022 | $0.28 | $0.25 | -10.71% | $110.2M | $117.1M |
| Q3 2021 | Nov 4, 2021 | $0.31 | $0.34 | 10.86% | $105.3M | $103.7M |

## Frequently Asked Questions

### When did Ironwood Pharmaceuticals (IRWD) last report earnings?

Ironwood Pharmaceuticals last reported on Aug 6, 2026, covering fiscal Q2 2026.

### Did IRWD beat earnings estimates?

No. Ironwood Pharmaceuticals reported EPS of $0.31 for Q2 2026 against a $0.32 estimate — a 3.13% miss.

### How much revenue did IRWD report last quarter?

Ironwood Pharmaceuticals reported $113.0M in revenue for Q2 2026, against a consensus estimate of $114.3M.

## Similar Stocks

- [ABBV](https://www.lighthorse.io/tickers/abbv) — AbbVie Inc. Common Stock

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).